Neuropace Inc (NPCE) FinancialsNPCENeuropace Inc

Evaluating the bottom line, NeuroPace, Inc. maintains a gross margin of 82.83%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -22.53%, while the net margin is -27.16%. These profitability ratios, combined with a Return on Equity (ROE) of -103.27%, provide a clear picture of how effectively NPCE converts its operational activities into shareholder value.

In the context of the broader market, NPCE competes directly with industry leaders such as YDES and RCEL. With a market capitalization of $438.32M, it holds a significant position in the sector. When comparing efficiency, NPCE's gross margin of 82.83% stands against YDES's 30.69% and RCEL's 82.09%. Such benchmarking helps identify whether NeuroPace, Inc. is trading at a premium or discount relative to its financial performance.

Neuropace has shown significant revenue growth potential, with Q1 2026 revenue reported at $22.1 million, an 8% year-over-year increase. The gross margin is strong at 81.78% for Q1 2026, indicating good profitability on sales.